Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Defence Therapeutics Inc (DTCFF)

Defence Therapeutics Inc (DTCFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Defence Therapeutics Opens New Office in Hamilton to Expand Its Accum Radiopharmaceutical Platform Newsfile - Wed Jul 8, 2:24AM CDT

Montreal, Quebec--(Newsfile Corp. - July 8, 2026) -   Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics to Participate in Bio International Convention 2026 Next Week for Strategic Partnership Discussions Newsfile - Wed Jun 17, 2:18AM CDT

Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors Newsfile - Wed Jun 3, 2:30AM CDT

Montreal, Quebec--(Newsfile Corp. - June 3, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its Board of Directors Newsfile - Mon Jun 1, 2:30AM CDT

Montreal, Quebec--(Newsfile Corp. - June 1, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics Strengthens Its Scientific Advisory Board with the Appointment of Dr. Sarkis Meterissian Newsfile - Fri May 29, 3:34PM CDT

Montreal, Quebec--(Newsfile Corp. - May 29, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC)  ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities Newsfile - Tue May 19, 2:30AM CDT

Montreal, Quebec--(Newsfile Corp. - May 19, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics Announces Grant of Restricted Stock Units Newsfile - Fri Apr 24, 5:42PM CDT

Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics Announces Warrant Terms Amendment Newsfile - Fri Mar 20, 5:12PM CDT

Montreal, Quebec--(Newsfile Corp. - March 20, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000 Newsfile - Mon Mar 9, 2:16AM CDT

Montreal, Quebec--(Newsfile Corp. - March 9, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March Newsfile - Mon Mar 2, 2:20AM CST

Montreal, Quebec--(Newsfile Corp. - March 2, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company advancing next-generation...

DTCFF : 0.3500 (+11.29%)
DTC.CN : 0.4150 (+5.06%)

Barchart Exclusives

HSBC Says Apple Is Entering a Powerful New Upgrade Cycle. What That Means for AAPL Stock. Barchart - 8 minutes ago
Apple stock is back near record highs after HSBC upgraded the iPhone maker, arguing that AI and an unusually strong hardware roadmap could drive its next major growth cycle. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.